AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Iterum Therapeutics plc Director's Dealing 2020

Nov 23, 2020

34796_dirs_2020-11-23_b5faff72-80c5-4b37-ada0-7e0bd9410061.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Iterum Therapeutics plc (ITRM)
CIK: 0001659323
Period of Report: 2020-11-22

Reporting Person: DENNER ALEXANDER J (10% Owner)
Reporting Person: Sarissa Capital Management LP (10% Owner)
Reporting Person: Sarissa Capital Offshore Master Fund LP (10% Owner)
Reporting Person: Sarissa Capital Catapult Fund LLC (10% Owner)
Reporting Person: Sarissa Capital Hawkeye Fund LP (10% Owner)
Reporting Person: Sarissa Capital Master Fund II LP (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
6.500% Exchangeable Senior Subordinated Note due 2025	$.7775	2025-01-31	Ordinary Shares (19292768)		Indirect

Footnotes

F1: See Exhibit 99.1

F2: See Exhibit 99.1

F3: See Exhibit 99.1

F4: See Exhibit 99.1